2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Publication
, Journal Article
Zamorano, JL; Lancellotti, P; Rodriguez Muñoz, D; Aboyans, V; Asteggiano, R; Galderisi, M; Habib, G; Lenihan, DJ; Lip, GYH; Lyon, AR; Mohty, D ...
Published in: Eur Heart J
September 21, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
September 21, 2016
Volume
37
Issue
36
Start / End Page
2768 / 2801
Location
England
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Societies, Medical
- Radiotherapy
- Neoplasms
- Immunotherapy
- Humans
- Cardiovascular System & Hematology
- Cardiotoxicity
- Cardiology
- Cancer Survivors
Citation
APA
Chicago
ICMJE
MLA
NLM
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., … ESC Scientific Document Group, . (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J, 37(36), 2768–2801. https://doi.org/10.1093/eurheartj/ehw211
Zamorano, Jose Luis, Patrizio Lancellotti, Daniel Rodriguez Muñoz, Victor Aboyans, Riccardo Asteggiano, Maurizio Galderisi, Gilbert Habib, et al. “2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).” Eur Heart J 37, no. 36 (September 21, 2016): 2768–2801. https://doi.org/10.1093/eurheartj/ehw211.
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016 Sep 21;37(36):2768–801.
Zamorano, Jose Luis, et al. “2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).” Eur Heart J, vol. 37, no. 36, Sept. 2016, pp. 2768–801. Pubmed, doi:10.1093/eurheartj/ehw211.
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM, ESC Scientific Document Group. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016 Sep 21;37(36):2768–2801.
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
September 21, 2016
Volume
37
Issue
36
Start / End Page
2768 / 2801
Location
England
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Societies, Medical
- Radiotherapy
- Neoplasms
- Immunotherapy
- Humans
- Cardiovascular System & Hematology
- Cardiotoxicity
- Cardiology
- Cancer Survivors